Thursday, May 26, 2022 3:23:04 PM
Decentral Life IR Team:
30 minutes ago
The question continues to come up about the market cap and share price, at the time of the R/S. So we addressed that in a communication string below. If you haven’t seen the response, here it is again…
Does everyone understand how an investment bank uses the reports provided by their Buy Side Analyst? …specifically in an IPO or up listing of the company that is being supported by their brokers.
Buy side analysts perform financial research on the company, deriving formulas and strategies that will help the buy side firm (investment bank, and their institutional investor clients) earn the highest possible risk-adjusted return on their capital investment.
An analysts research is used to build financial models for growth of the companies they report on. Along with other KPI’s, this includes market cap comparisons on private and public companies that closely resemble the company they are reporting on. (In our case, that comparison report used Y Combinator, Techstars, and Angelpad to name just a few.)
The report closely pegs the target stock price (or market cap) that the brokers will support. This step is generally finalized after the completion of the roadshow that takes place prior to the IPO or up listing. The feedback from the roadshow provides important guidance on institutional support during the IPO or up listing.
It is very important to note that a buy side analyst recommendations are made available exclusively to the investment bank that employs them. It is not made public… meaning retail shareholders never know what the brokers and their institutional investor clients know from that report.
So to assume that retail shareholder support of a stock at the time of an IPO or up listing, will determine the market cap previously established for that company by the investment bankers and their buy side analyst, is an inaccurate assumption.
We hope this provides some additional clarity… clearing up any confusion on how we arrived at our target market cap (and thus, minimum stock price of $0.05 for the R/S.)
~ $WDLF / Decentral Life ~
~ Tic, toc, . . .
Recent WDLF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:26:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:03:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:57:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:50:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:00:10 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/08/2023 06:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:41:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 08:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 10:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:52:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 06:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 09:25:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 12:00:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 08:57:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:39:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM